ClinVar Genomic variation as it relates to human health
NM_030632.3(ASXL3):c.3349C>T (p.Arg1117Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_030632.3(ASXL3):c.3349C>T (p.Arg1117Ter)
Variation ID: 279694 Accession: VCV000279694.12
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 18q12.1 18: 33743197 (GRCh38) [ NCBI UCSC ] 18: 31323161 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Dec 6, 2016 Mar 23, 2024 Mar 11, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_030632.3:c.3349C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_085135.1:p.Arg1117Ter nonsense NC_000018.10:g.33743197C>T NC_000018.9:g.31323161C>T NG_055244.1:g.169621C>T - Protein change
- R1117*
- Other names
- -
- Canonical SPDI
- NC_000018.10:33743196:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
ASXL3 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
770 | 811 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (6) |
criteria provided, multiple submitters, no conflicts
|
Mar 11, 2024 | RCV000263069.8 | |
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Sep 19, 2019 | RCV000271358.7 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Nov 05, 2015)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000336692.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 1
Sex: mixed
|
|
Pathogenic
(Sep 19, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000329090.5
First in ClinVar: Dec 06, 2016 Last updated: Dec 06, 2016 |
Comment:
Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 1132 amino acids are lost, and other loss-of-function variants have been … (more)
Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 1132 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 28362156, 26633542, 29429203, 33258288) (less)
|
|
Pathogenic
(Nov 25, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome
Affected status: yes
Allele origin:
germline
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Accession: SCV003806916.1
First in ClinVar: Mar 04, 2023 Last updated: Mar 04, 2023 |
Comment:
ACMG classification criteria: PVS1 very strong, PS4 supporting, PM2 moderated
Number of individuals with the variant: 1
Clinical Features:
Thin upper lip vermilion (present) , Diastasis recti (present) , Microcephaly (present) , Strabismus (present) , Anxiety (present) , Long eyelashes (present) , Decreased body … (more)
Thin upper lip vermilion (present) , Diastasis recti (present) , Microcephaly (present) , Strabismus (present) , Anxiety (present) , Long eyelashes (present) , Decreased body weight (present) , Narrow forehead (present) , Short stature (present) , Global developmental delay (present) , Hypertelorism (present) , Highly arched eyebrow (present) , Bulbous nose (present) , Smooth philtrum (present) , Synophrys (present) , Clinodactyly of the 5th finger (present) , Short philtrum (present) , Generalized hypertrichosis (present) , Prolonged neonatal jaundice (present) , Gestational diabetes (present) , Renal cyst (present) (less)
Geographic origin: Brazil
Method: Paired-end whole-genome sequencing
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV000807288.3
First in ClinVar: Dec 06, 2016 Last updated: Mar 18, 2023 |
|
|
Pathogenic
(Mar 11, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
de novo
|
Centre for Inherited Metabolic Diseases, Karolinska University Hospital
Accession: SCV004708219.1
First in ClinVar: Mar 16, 2024 Last updated: Mar 16, 2024 |
|
|
Likely pathogenic
(Dec 01, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome
Affected status: unknown
Allele origin:
unknown
|
Illumina Laboratory Services, Illumina
Accession: SCV004801622.1
First in ClinVar: Mar 23, 2024 Last updated: Mar 23, 2024 |
Comment:
The ASXL3 c.3349C>T p.(Arg1117Ter) nonsense variant occurs in the last exon of the gene and the resulting transcript may escape nonsense-mediated mRNA decay. This variant … (more)
The ASXL3 c.3349C>T p.(Arg1117Ter) nonsense variant occurs in the last exon of the gene and the resulting transcript may escape nonsense-mediated mRNA decay. This variant has been identified in individuals with a phenotype consistent with Bainbridge-Ropers syndrome, including in a de novo state in at least one individual (Hedge et al. 2017; Zhang et al. 2018). This variant is not observed in version 2.1.1 of the Genome Aggregation Database. Based on the available evidence, the c.3349C>T p.(Arg1117Ter) variant is classified as likely pathogenic for Bainbridge-Ropers syndrome. (less)
|
|
Pathogenic
(Nov 30, 2018)
|
no assertion criteria provided
Method: provider interpretation
|
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome
Affected status: yes
Allele origin:
de novo,
unknown
|
GenomeConnect - Simons Searchlight
Accession: SCV001443485.1
First in ClinVar: Nov 21, 2020 Last updated: Nov 21, 2020 |
Comment:
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-11-30 and interpreted as Pathogenic. The reporting laboratory … (more)
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-11-30 and interpreted as Pathogenic. The reporting laboratory might also submit to ClinVar. (less)
Observation 1:
Number of individuals with the variant: 1
Sex: male
Testing laboratory: GeneDx
Date variant was reported to submitter: 2013-12-23
Testing laboratory interpretation: other
Observation 2:
Number of individuals with the variant: 1
Sex: female
Testing laboratory: Azienda Ospedaliero Universitaria
Date variant was reported to submitter: 2018-06-08
Testing laboratory interpretation: Pathogenic
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: research
|
Bainbridge-Ropers syndrome
Affected status: yes
Allele origin:
de novo
|
Pediatric Department, Xiangya Hospital, Central South University
Accession: SCV004032217.1
First in ClinVar: Sep 09, 2023 Last updated: Sep 09, 2023 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ASXL3 | - | - | - | - |
Text-mined citations for rs868044680 ...
HelpRecord last updated Mar 23, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.